Getting latest data loading
Home / Morning Report / Morning Report – 22nd July 2025

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 22 July 2025

Yesterday’s UK 100 Leaders Price (p) % Chg
Antofagasta PLC 1,956.5 4.7%
Endeavour Mining PLC 2,284.0 4.1%
Fresnillo PLC 1,497.0 3.6%
Anglo American PLC 2,307.0 3.3%
Marks And Spencer Group PLC 352.4 3.0%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
BAE Systems PLC 1,900.5 -2.0%
Informa PLC 822.4 -1.7%
Diageo PLC 1,897.0 -1.7%
London Stock Exchange Group PLC 10,655.0 -1.6%
Haleon PLC 354.3 -1.2%

 

Major World Indices Price % Chg 1 Year
UK 100 INDEX 9,013 0.2% 9.9%
DOW JONES INDUS. AVG 44,323 0.0% 9.7%
DAX INDEX 24,308 0.1% 32.1%
NIKKEI 225 39,775 -0.1% 0.3%
S&P/ASX 200 INDEX 8,677 0.1% 9.4%

 

Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 66.60 -0.89%
Brent Crude (ICE) USD/bbl. 68.83 -0.55%
Gold Spot USD/t oz. 3,385 -0.3%
Copper (Comex) USd/lb. 563 -0.2%

 

The UK 100 called to open -22 points this morning at 8,990.

4 Hours; 7 Months

Click graph to enlarge

Markets Overview:

 

The UK 100 called to open -22 points this morning at 8,990. The UK 100 looks set to open slightly lower this morning, matching expected similar declines across other European markets.  Data out this morning showed that UK public sector net borrowing rose more than expected in June, raising to £20.7 Billion from a previous read of £17.7 Billion in May.

The S&P moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments in trade.  The broad market index rose 0.14% and closed at 6,305.60 — marking the first time it ended a session above the 6,300 threshold. The Nasdaq jumped 0.38% for a closing record of 20,974.17. Both indexes hit new all-time intraday highs earlier in the session, bolstered by advances in major technology names like Meta Platforms and Amazon. The Dow Jones slipped 19.12 points, or 0.04%, and settled at 44,323.07.  This comes as earnings season is off to a strong start. Verizon shares popped 4% following a second-quarter earnings beat, spurring excitement that other reports will come in strong. It joins 62 S&P companies that have reported thus far. Of those, more than 85% have topped expectations, according to FactSet data. Earnings for the second quarter are also tracking 5% year-over-year growth following the first week of results, per Bank of America.

Asian shares were mixed on Tuesday.  Japan’s benchmark surged and then fell back as it reopened from a holiday Monday following the ruling coalition’s loss of its upper house majority in Sunday’s election.  The Nikkei 225 shed 0.3% to 39,694.89.  Elsewhere in Asia, Hong Kong’s Hang Seng rose 0.3% to 25,057.11, while the Shanghai Composite index also was up 0.3%, at 3,568.78.  South Korea’s Kospi sank 1.4% to 3,165.40, with investors concerned over the Aug. 1 deadline for making a deal with U.S. President Donald Trump or facing 25% tariffs on all the country’s exports to the U.S.  Australia’s S&P/ASX 200 was little changed at 8,666.30.

 

Company News & Broker Comments:

 

Company News:

AstraZeneca unveils £50bn US investment plan.  The pharmaceuticals giant AstraZeneca today announced plans for $50 billion of investment in the United States by 2030.  The flagship project will be a new multi-billion dollar US manufacturing facility that will produce drug substances for the company’s weight management and metabolic portfolio.  The state-of-the-art centre in Virginia would be AstraZeneca’s largest single manufacturing investment in the world, leveraging AI, automation and data analytics to optimise production.  Howard Lutnick, US Secretary of Commerce, said: “For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation’s new tariff policies are focused on ending this structural weakness.

 

Compass unveils £1.3bn acquisition, upgrades guidance.  Catering group Compass is to acquire European food services business Vermaat in a deal worth 1.5 billion euros (£1.3 billion).  Vermaat is the market leader in the Netherlands, with a growing presence in Germany and France — all of which are top ten markets for Compass.  Compass chief executive Dominic Blakemore said: “This strategic acquisition represents a step change in our core markets by creating a strong platform for expansion across Europe.”  As well as the deal, Compass upgraded guidance for 2025 after reporting organic revenue growth of 8.6% in the third quarter and 8.5% for the year to date.  The group now expects constant currency underlying operating profit growth to be towards 11%, driven by organic revenue growth above 8% and ongoing margin progression.

Reporting Today:

 

UK

TheWorks.co.uk (WRKS)

Compass Group (CPG)

Evoke (EVOK)

US

Coca-Cola (KO) PMO

GE Aerospace (GE) PMO

General Motors (GM) PMO

Philip Morris International (PM) PMO

Intuitive Surgical (ISRG) AMC

Reporting Tomorrow:

 

UK

Breedon Group (BREE)

J D Wetherspoon (JDW)

Informa (INF)

US

AT&T (T) PMO

CME Group (CME) PMO

GE Vernova (GEV) PMO

Thermo Fisher Scientific (TMO) PMO

Alphabet Inc (GOOG) AMC

International Business Machines (IBM) AMC

QuantumScape (QS) AMC

ServiceNow (NOW) AMC

Tesla (TSLA) AMC

In Focus Today:

ECB Bank Lending Survey

This Week’s Ex-Dividends:

 

UK 100 companies going ex-dividend on 24th July 2025:

SSE

 

 

UK 250 companies going ex-dividend on 24th July 2025:

QinetiQ Group

Bloomsbury Publishing

Pennon Group

Telecom Plus

Supermarket Income REIT

 

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.